The purpose of this project is to develop an at-home diagnostic device that can quantify the level of risk of developing preeclampsia based on the biomarker levels detected. This screening tool will provide the opportunity for early intervention and increased monitoring if a high risk of preeclampsia is detected, ultimately reducing disease severity and the risk of maternal and neonatal mortality.